U.S., Nov. 19 -- An application to own the trademark for 'SYMREPLIQ' has been filed on Apr. 28, 2025.
Owner(s):
Gamida Cell Inc.; 780 5th Ave S, Suite 200, FLORIDA
Goods and/or Services:
For: Pharmaceutical preparations for cellular therapy for use in the hematology and oncology fields for the treatment of leukemia, and blood and bone marrow diseases and disorders; pharmaceutical preparations in the field of hematology and oncology, for the treatment of leukemia, and blood and bone marrow diseases and disorders
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-11-18&serialNumber=99159217
Disclaimer: Curated by HT Syndication....